Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF COMMERCIAL OFFICER

Chief Operations Officer

Chief Commercial Officer

CEO and President

Chief Operating Officer

CEO, Pres, CFO, Treas & Secy

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodi...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-15	Premium	bought	Premium	Premium	Premium	-
2024-03-28	Premium	bought	Premium	Premium	Premium	-
2024-03-18	Premium	acquired	Premium	Premium	Premium	-
2024-03-07	Premium	bought	Premium	Premium	Premium	CHIEF COMMERCIAL OFFICER
2023-04-20	Premium	sold	Premium	Premium	Premium	Chief Operations Officer
2023-01-20	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-01-19	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-01-18	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-01-17	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2022-12-28	Premium	acquired	Premium	Premium	Premium	-
2022-10-07	Premium	bought	Premium	Premium	Premium	-
2022-10-07	Premium	bought	Premium	Premium	Premium	-
2022-10-06	Premium	bought	Premium	Premium	Premium	-
2022-10-05	Premium	bought	Premium	Premium	Premium	-
2022-10-04	Premium	bought	Premium	Premium	Premium	-
2022-10-03	Premium	bought	Premium	Premium	Premium	-
2022-09-30	Premium	bought	Premium	Premium	Premium	-
2022-09-29	Premium	bought	Premium	Premium	Premium	-
2022-06-21	Premium	bought	Premium	Premium	Premium	CEO and President
2022-06-21	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2022-04-21	Premium	acquired	Premium	Premium	Premium	-
2022-04-21	Premium	sold	Premium	Premium	Premium	-
2022-04-21	Premium	acquired	Premium	Premium	Premium	-
2022-03-01	Premium	bought	Premium	Premium	Premium	-
2022-02-28	Premium	bought	Premium	Premium	Premium	-

OTLK - Outlook Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for OTLK